SOAR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Volato Group, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Volato Group, Inc. (NYSE: SOAR) and M2i Global, Inc. is fair to Volato shareholders. Upon completion of the proposed transaction, current Volato shareholders will own approximately 10% of the combined company.
Halper Sadeh encourages Volato shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.
The investigation concerns whether Volato and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Volato shareholders; and (2) disclose all material information necessary for Volato shareholders to adequately assess and value the merger consideration.
On behalf of Volato shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
The Goldman Sachs Group (GS) Continues to Lead in Global Finance
The Goldman Sachs Group, Inc. (NYSE:GS) is one of the Best Dividend Stocks of 2025. A close-up of a financial advisor giving advice to a customer, demonstrating the importance of consumer and wealth management. The stock has surged by 16.5% since the start of 2025. In its Q1 2025 earnings report, the company reported leading the industry in several key areas. It secured the top spot globally for both announced and completed mergers and acquisitions, equity and equity-related offerings, as well as common stock offerings. It also ranked second in high-yield debt and leveraged loan offerings for the year to date. The Global Banking & Markets division generated $10.71 billion in net revenues, driven by record performance in Equities— particularly in financing— along with strong results in Fixed Income, Currency and Commodities, which also included record financing revenues. Debt underwriting also contributed to the division's strong showing. Overall, The Goldman Sachs Group, Inc. (NYSE:GS) reported its third-highest quarterly net revenues at $15.06 billion, alongside robust net earnings of $4.74 billion and diluted earnings per share of $14.12. Shareholder returns remained healthy, with $976 million distributed through common stock dividends. Additionally, the Board approved a new share repurchase program authorizing buybacks of up to $40 billion in common stock. The Goldman Sachs Group, Inc. (NYSE:GS) is a strong dividend company that has paid regular dividends to shareholders since 1999. Its current quarterly dividend is $3.00 per share for a dividend yield of 1.75%, as of June 26. While we acknowledge the potential of GS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None.
Yahoo
44 minutes ago
- Yahoo
The Mosaic Company (MOS) Beat the Market in 2025 on Strong Phosphate and Potash Sales
The Mosaic Company (NYSE:MOS) is one of the Best Dividend Stocks of 2025. A farmer tending to his crops in a field, with a fertiliser bag nearby. The company raised its potash production plans for 2025 to meet rising international demand. In the phosphate segment, maintenance work and efforts to restore the health of US assets are showing promising outcomes, with strong production recorded in March, even with scheduled downtime. The Bartow phosphate facility is currently operating at its target capacity and is on track to produce over 500,000 tonnes in the second quarter, which aligns with an annual output exceeding 2 million tonnes. Production at the New Wales phosphate facility is also projected to rise by more than 20% in the second quarter compared to the first. In its first-quarter earnings report, The Mosaic Company (NYSE:MOS) stated that the company is advancing well across various areas and is positioned to create substantial value for shareholders in 2025 and the years ahead. During the quarter, it returned $71 million to shareholders through dividends. Currently, it pays a quarterly dividend of $0.22 per share for a dividend yield of 2.50%, as of June 26. The stock is up by over 45% since the start of 2025. While we acknowledge the potential of MOS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
CVS Health Corporation (CVS) Outpaces Broader Market with Strong 2025 Rally
CVS Health Corporation (NYSE:CVS) is one of the Best Dividend Stocks of 2025. A row of shelves in a retail pharmacy, demonstrating the variety of drugs and over-the-counter products. Following a challenging year in 2024, CVS Health Corporation (NYSE:CVS) appears to be making progress toward a recovery. The company remains committed to becoming the most trusted healthcare provider in the United States by delivering improved care, value, and service through its integrated and industry-leading operations. The stock has surged by over 50% since the start of 2025. With a strong focus on customer needs, CVS Health Corporation (NYSE:CVS) reported positive results across its Health Care Benefits, Health Services, and Pharmacy and Consumer Wellness segments. The company continues working toward its goal of building a healthier future for the 185 million individuals it serves. CVS Health Corporation (NYSE:CVS) also updated its full-year 2025 guidance for GAAP diluted earnings per share, adjusted earnings per share, and operating cash flow to reflect strong performance across all business areas. However, the company is maintaining a cautious outlook for the rest of the year due to ongoing elevated cost trends and potential broader economic challenges. CVS Health Corporation (NYSE:CVS) has paid regular dividends to shareholders since 1997. The company's quarterly dividend comes in at $0.665 per share for a dividend yield of 3.90%, as of June 26. While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Sign in to access your portfolio
